Drug Report History

Return to report

Below you will find the report version history. When a report is updated, a new version of the report is created. The report history allows you to see the changes between versions. You can select two versions of the report to compare. The fields that were changed between versions will be highlighted in yellow.

The translation of reports creates two separate versions which is why some reports may not seem to have any differences. In this case, only the language field below will be highlighted in yellow.

Version v4-FR Version v3-EN
Language French English
Date Updated 2020-02-13 2020-02-13
Drug Identification Number 02231895 02231895
Brand name METHYLPREDNISOLONE SODIUM SUCCINATE FOR INJECTION METHYLPREDNISOLONE SODIUM SUCCINATE FOR INJECTION
Common or Proper name METHYLPREDNISOLONE METHYLPREDNISOLONE
Company Name TEVA CANADA LIMITED TEVA CANADA LIMITED
Ingredients METHYLPREDNISOLONE METHYLPREDNISOLONE
Strength(s) 500MG 500MG
Dosage form(s) POWDER FOR SOLUTION POWDER FOR SOLUTION
Route of administration INTRAMUSCULAR INTRAVENOUS INTRAMUSCULAR INTRAVENOUS
Packaging size 5 5
ATC code H02AB H02AB
ATC description CORTICOSTEROIDS FOR SYSTEMIC USE, PLAIN CORTICOSTEROIDS FOR SYSTEMIC USE, PLAIN
Reason for shortage Disruption of the manufacture of the drug. Disruption of the manufacture of the drug.
Anticipated start date
Actual start date 2016-02-29 2016-02-29
Estimated end date 2022-12-01 2022-12-01
Actual end date
Shortage status Actual shortage Actual shortage
Tier 3 Status No No
Company comments
Health Canada comments